DocTel Medicanna · Tasmania

Medical Cannabis Tasmania: online consultations from Hobart to regional communities

For Tasmanians considering medicinal cannabis, geography can change the practicalities of care — not the clinical standard. DocTel provides online assessment with Australian practitioners, with prescribing considered only where clinically appropriate and lawful.

An island-state reality

Tasmania looks compact on a map; real journeys to healthcare can still be long.

One clinical threshold. Different practical routes.

A person in central Hobart may have straightforward access to pathology, imaging and pharmacy services. Someone on the North West Coast, East Coast or in a smaller rural community may need to plan around distance, local stock and delivery. Telehealth can remove one part of that travel burden, but it does not remove the need for sound clinical assessment.

Medicinal cannabis is not automatically suitable because a consultation occurs online. The practitioner still considers the condition being treated, previous therapies, current medicines, relevant risks and whether an in-person examination or investigation is needed.

How cannabis telehealth works in Australia

North / South / Between

Place changes the route around care.

Hobart and Launceston anchor Tasmania's two largest population centres. Beyond them, longer journeys, pharmacy logistics and access to local services can become part of the practical planning around care.

SOUTH

Hobart and southern Tasmania

Telehealth can reduce cross-city travel for assessment and review. If treatment is prescribed, dispensing remains a pharmacy function and depends on a lawful prescription and pharmacy arrangements. Physical examination or local investigations may still be needed when the clinical picture requires them.

NORTH

Launceston and the north

The same assessment standard applies in Launceston. Online review may make continuity easier, while pharmacy supply, pathology and face-to-face care remain local matters that may need coordination outside the telehealth consultation.

BETWEEN

North West, East Coast and rural Tasmania

For people around Burnie, Devonport, the Huon Valley and smaller communities, telehealth can avoid unnecessary kilometres for a suitable consultation. Local stock, regulatory requirements, urgent care and examination-based care remain separate practical considerations.

The clinical lens

Before prescribing is even considered

A medicinal cannabis consultation is a clinical assessment, not a product-selection exercise. These are the kinds of questions that shape a safe decision.

01
Why now?
What symptoms or diagnosis are being managed, how long have they been present, and what has changed enough to prompt another treatment discussion?
02
What has already been tried?
Previous medicines, non-drug therapies, procedures and their outcomes matter. For most unapproved medicinal cannabis products, the Commonwealth access framework expects clinically appropriate ARTG-listed options to have been considered.
03
What else is being taken?
Prescription medicines, over-the-counter products and other substances can alter risk. The practitioner needs an accurate medication history rather than an isolated cannabis request.
04
Where is the risk?
Mental-health history, substance-use history, pregnancy, cardiovascular considerations and other clinical factors may change whether treatment is appropriate or whether further assessment is needed.
05
What does daily life demand?
Driving, safety-sensitive work, caring responsibilities, cognition and daytime function can materially affect the risk-benefit discussion.
06
How would treatment be reviewed?
If prescribed, follow-up should examine benefit, adverse effects, function and whether continuing treatment remains justified. A prescription is not the end of clinical care.

Read the full prescription assessment guide

Tasmania's legal layer

Commonwealth access sits beside Tasmanian controlled-drug law

Most medicinal cannabis products in Australia are unapproved therapeutic goods. The TGA provides access pathways including the Special Access Scheme and Authorised Prescriber scheme. Clinical suitability and the applicable Commonwealth pathway are only part of the picture: state law still matters.

Tasmania's current Poisons Regulations specifically list cannabis and tetrahydrocannabinol among narcotic substances for which a medical practitioner or nurse practitioner must not issue a prescription or supply to a patient without the authority of the Secretary, subject to the regulatory framework and any applicable authorisation.

That makes Tasmania materially different from states where the state layer is lighter for routine adult prescribing. The correct question is not simply whether medicinal cannabis is legal; it is whether the practitioner, patient, medicine and proposed prescribing arrangement satisfy the applicable Commonwealth and Tasmanian requirements.

Australian medicinal cannabis regulation guide

Commonwealth

The TGA says most medicinal cannabis remains outside the ARTG and is accessed through pathways such as SAS or AP when clinically appropriate.

Tasmania

The Poisons Regulations 2018 contain a specific Secretary-authority requirement for prescribing or supplying cannabis and THC listed under regulation 24.

Prescriber responsibility

TGA approval or an access pathway does not compel a practitioner to prescribe. The clinical decision remains with the prescriber.

Interstate prescriptions

The Poisons Amendment (Interstate Prescriptions) Act 2025 commenced on 16 February 2026 and brought interstate prescribers and prescriptions into Tasmania's framework. This can include Schedule 8 medicinal cannabis, but it does not make every interstate prescription dispensable: Tasmanian prescription rules, monitored-medicine checks, any required authority and lawful pharmacy dispensing still apply.

From decision to dispensing

A prescription crosses professional boundaries

Practitioner

Assesses clinical suitability, regulatory requirements and whether prescribing is justified.

Prescription

If issued, it must meet the legal requirements that apply to the medicine and prescribing circumstances.

Pharmacy

Dispensing is a separate professional act. A pharmacy must be able to lawfully dispense the prescription and have, or obtain, the prescribed medicine.

For regional Tasmania, pharmacy availability and delivery can become more important than the consultation itself. A prescription does not guarantee immediate stock or same-day supply.

Clinical and commercial roles stay separate

DocTel's role is the clinical service. Medication sales are not a DocTel revenue stream. Prescribing remains an independent clinical decision, and dispensing remains with the pharmacy.

Medication markup: $0
Pharmacy commission: $0
Medication-linked benefit: $0
Hobart / Launceston

Two urban anchors, one standard

Hobart and Launceston patients may be able to complete suitable consultations by telehealth. Being in a larger centre can make local investigations and pharmacy coordination easier, but it does not alter the threshold for prescribing.

Hobart

Online consultation can reduce travel across greater Hobart for assessment and follow-up. Where examination, pathology or other care is needed, that part of care still occurs locally.

Launceston

Northern Tasmanian patients use the same clinical process. Follow-up can remain online when appropriate, while dispensing and any physical healthcare are coordinated separately.

Regional Tasmania

When distance becomes part of the care plan

Outside the larger centres, telehealth can solve the consultation-distance problem without pretending to solve every healthcare problem.

  • Local pharmacy stock may vary.
  • Delivery times can matter when a medicine is not held locally.
  • Pathology, imaging or examination may need a nearby service.
  • Urgent symptoms still require urgent local assessment.
  • Continuity with a regular GP may be important when other conditions or medicines affect the decision.
Driving in Tasmania

Tasmania has an important legal distinction

Presence and impairment are not the same offence

THC is listed as a prescribed illicit drug for Tasmania's roadside drug-driving regime. Section 6A of the Road Safety (Alcohol and Drugs) Act 1970 creates an offence for driving with a prescribed illicit drug present in blood or oral fluid, but subsection 6A(2) provides the exception described above for lawful obtaining and administration under the Poisons Act.

That does not create permission to drive while impaired. Tasmania separately prohibits driving while under the influence of a drug to the extent that the driver is incapable of proper control. Patients should discuss driving, impairment and the characteristics of any prescribed medicine with their practitioner rather than assuming a prescription makes driving safe.

CBD-only medicines present a different issue from THC-containing medicines because roadside THC laws concern THC. Individual products and circumstances still need to be considered clinically.

The Act does not create a separate rule for prescriptions issued after telehealth assessment. Any prescription relied on must still satisfy the Poisons Act framework, and whether the statutory exception is established depends on lawful obtaining and administration in the individual circumstances. The legislation does not state that prescription evidence must be carried while driving.

Read the broader cannabis safety guide

Cost without the sales pitch

Separate the consultation from the medicine

The total cost of care can involve more than one transaction. Consultation fees belong to the clinical service. Medicine, dispensing and any delivery are separate pharmacy costs.

See the Australian cost guide

Initial assessmentDocTel clinical service
Follow-upClinical review when required
MedicineDepends on what is prescribed
Dispensing / deliveryPharmacy arrangements
Tasmania questions

The questions Tasmanian patients actually ask

These answers describe the framework, not an individual eligibility decision.

Can a medicinal cannabis consultation be done by telehealth in Tasmania?

Yes, assessment may be conducted by telehealth where the practitioner considers that format clinically appropriate. Online consultation does not guarantee prescribing, and an in-person examination or investigation may still be required.

Does Tasmania have its own approval requirement for THC-containing medicinal cannabis?

Tasmania's Poisons Regulations specifically require Secretary authority for a medical practitioner or nurse practitioner to prescribe or supply listed narcotic substances including cannabis and tetrahydrocannabinol, subject to the applicable regulatory framework and authorisations.

Can patients in Hobart use the same online service as regional patients?

Yes. The clinical assessment standard is the same. What can differ is the practical work around the consultation, including local investigations, pharmacy stock and delivery.

What about Launceston and northern Tasmania?

Suitable consultations can also be conducted online for patients in Launceston and northern Tasmania. Any prescription, dispensing or local examination requirements remain separate parts of care.

Does living in Burnie or Devonport make medicinal cannabis harder to access?

It should not lower or raise the clinical threshold. Regional location can, however, affect pharmacy availability, delivery time and access to face-to-face investigations if they are needed.

Does a consultation mean I will receive a prescription?

No. The practitioner may prescribe only when treatment is clinically appropriate and the relevant legal requirements can be met. They may recommend another treatment, further information or face-to-face care instead.

Can a Tasmanian pharmacy dispense medicinal cannabis?

A pharmacy may dispense where it can lawfully do so from a valid prescription and satisfy the applicable controlled-medicine requirements. Stock is a separate issue and should not be assumed.

Can I drive in Tasmania if I am lawfully prescribed THC?

Tasmania's presence offence contains an exception where the prescribed illicit drug was obtained and administered in accordance with the Poisons Act 1971. This does not permit impaired driving; a separate offence applies to driving while under the influence of a drug to the point of being incapable of proper control.

How much does medicinal cannabis cost in Tasmania?

Costs can include the clinical consultation, follow-up, the prescribed medicine, dispensing and delivery. Medicine cost varies by prescription. DocTel does not earn medication markup or pharmacy commission.

What happens if I need examination, pathology or imaging?

Telehealth cannot replace every form of healthcare. If physical examination or investigations are clinically necessary, the practitioner may recommend that they be completed locally before or alongside further telehealth care.

DocTel Medicanna

Begin with the clinical facts.

Book an online Medicanna consultation for Tasmania. Prescribing is considered only after clinical assessment and where the applicable Commonwealth and Tasmanian requirements can be met.